Cargando…
The Azaindole Framework in the Design of Kinase Inhibitors
This review article illustrates the growing use of azaindole derivatives as kinase inhibitors and their contribution to drug discovery and innovation. The different protein kinases which have served as targets and the known molecules which have emerged from medicinal chemistry and Fragment-Based Dru...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6271083/ https://www.ncbi.nlm.nih.gov/pubmed/25460315 http://dx.doi.org/10.3390/molecules191219935 |
_version_ | 1783376846832795648 |
---|---|
author | Mérour, Jean-Yves Buron, Frédéric Plé, Karen Bonnet, Pascal Routier, Sylvain |
author_facet | Mérour, Jean-Yves Buron, Frédéric Plé, Karen Bonnet, Pascal Routier, Sylvain |
author_sort | Mérour, Jean-Yves |
collection | PubMed |
description | This review article illustrates the growing use of azaindole derivatives as kinase inhibitors and their contribution to drug discovery and innovation. The different protein kinases which have served as targets and the known molecules which have emerged from medicinal chemistry and Fragment-Based Drug Discovery (FBDD) programs are presented. The various synthetic routes used to access these compounds and the chemical pathways leading to their synthesis are also discussed. An analysis of their mode of binding based on X-ray crystallography data gives structural insights for the design of more potent and selective inhibitors. |
format | Online Article Text |
id | pubmed-6271083 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-62710832018-12-28 The Azaindole Framework in the Design of Kinase Inhibitors Mérour, Jean-Yves Buron, Frédéric Plé, Karen Bonnet, Pascal Routier, Sylvain Molecules Review This review article illustrates the growing use of azaindole derivatives as kinase inhibitors and their contribution to drug discovery and innovation. The different protein kinases which have served as targets and the known molecules which have emerged from medicinal chemistry and Fragment-Based Drug Discovery (FBDD) programs are presented. The various synthetic routes used to access these compounds and the chemical pathways leading to their synthesis are also discussed. An analysis of their mode of binding based on X-ray crystallography data gives structural insights for the design of more potent and selective inhibitors. MDPI 2014-11-28 /pmc/articles/PMC6271083/ /pubmed/25460315 http://dx.doi.org/10.3390/molecules191219935 Text en © 2014 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Mérour, Jean-Yves Buron, Frédéric Plé, Karen Bonnet, Pascal Routier, Sylvain The Azaindole Framework in the Design of Kinase Inhibitors |
title | The Azaindole Framework in the Design of Kinase Inhibitors |
title_full | The Azaindole Framework in the Design of Kinase Inhibitors |
title_fullStr | The Azaindole Framework in the Design of Kinase Inhibitors |
title_full_unstemmed | The Azaindole Framework in the Design of Kinase Inhibitors |
title_short | The Azaindole Framework in the Design of Kinase Inhibitors |
title_sort | azaindole framework in the design of kinase inhibitors |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6271083/ https://www.ncbi.nlm.nih.gov/pubmed/25460315 http://dx.doi.org/10.3390/molecules191219935 |
work_keys_str_mv | AT merourjeanyves theazaindoleframeworkinthedesignofkinaseinhibitors AT buronfrederic theazaindoleframeworkinthedesignofkinaseinhibitors AT plekaren theazaindoleframeworkinthedesignofkinaseinhibitors AT bonnetpascal theazaindoleframeworkinthedesignofkinaseinhibitors AT routiersylvain theazaindoleframeworkinthedesignofkinaseinhibitors AT merourjeanyves azaindoleframeworkinthedesignofkinaseinhibitors AT buronfrederic azaindoleframeworkinthedesignofkinaseinhibitors AT plekaren azaindoleframeworkinthedesignofkinaseinhibitors AT bonnetpascal azaindoleframeworkinthedesignofkinaseinhibitors AT routiersylvain azaindoleframeworkinthedesignofkinaseinhibitors |